Fredun Pharmaceuticals Limited at its board meeting held on May 07, 2024 recommended Final Dividend at 7% per Equity Share having Face Value of INR 10/each for the Financial Year 2023-24; subject to the approval of the Shareholders at the upcoming 37th Annual General Meeting of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
918.2 INR | +15.49% | +14.65% | +5.69% |
05-10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
05-08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
+5.69% | 44.77M | |
+48.79% | 781B | |
+41.37% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.26% | 248B | |
-0.20% | 221B | |
+11.55% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24